Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder

被引：0
|
作者：
Greg W Mattingly
Richard H Weisler
Joel Young
Ben Adeyi
Bryan Dirks
Thomas Babcock
Robert Lasser
Brian Scheckner
David W Goodman
机构：
[1] St Charles Psychiatric Associates/Midwest Research,Duke University Medical Center
[2] 4801 Weldon Spring Pkwy,undefined
[3] Durham,undefined
[4] NC,undefined
[5] and University of North Carolina at Chapel Hill,undefined
[6] Rochester Center for Behavioral Medicine,undefined
[7] Shire Development LLC,undefined
[8] Formerly of Shire Development LLC,undefined
[9] Johns Hopkins University School of Medicine,undefined
来源：
BMC Psychiatry | / 13卷
关键词：
Lisdexamfetamine dimesylate (LDX); Attention-deficit/hyperactivity disorder (ADHD); Adults; Response; Remission;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Clinical Utility of Lisdexamfetamine for the Management of Attention-Deficit Hyperactivity Disorder
    Nguyen, M.
    Shapiro, M. A.
    Tharani, S.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2012, 4 : 85 - 95
  • [42] Cost-utility Analysis of Lisdexamfetamine Dimesylate in the Treatment of Adults with Attention-deficit/hyperactivity Disorder in the United Kingdom
    Zimovetz, E. A.
    Bischof, M.
    Joseph, A.
    Mauskopf, J. A.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [43] Participant-Perceived Quality of Life in a Long-Term, Open-Label Trial of Lisdexamfetamine Dimesylate in Adolescents with Attention-Deficit/Hyperactivity Disorder
    Childress, Ann C.
    Cutler, Andrew J.
    Saylor, Keith
    Gasior, Maria
    Hamdani, Mohamed
    Ferreira-Cornwell, M. Celeste
    Findling, Robert L.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2014, 24 (04) : 210 - 217
  • [44] Long-term prognosis in attention-deficit/hyperactivity disorder
    Mannuzza, S
    Klein, RG
    CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2000, 9 (03) : 711 - +
  • [45] Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use
    Rakesh Jain
    Thomas Babcock
    Teodor Burtea
    Bryan Dirks
    Ben Adeyi
    Brian Scheckner
    Robert Lasser
    John Renna
    Don Duncan
    Advances in Therapy, 2013, 30 : 472 - 486
  • [46] Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents
    Mattos, Paulo
    REVISTA DE PSIQUIATRIA CLINICA, 2014, 41 (02): : 34 - 39
  • [47] Pharmacokinetic and Pharmacodynamic Properties of Lisdexamfetamine in Adults with Attention-Deficit/Hyperactivity Disorder
    Adler, Lenard A.
    Alperin, Samuel
    Leon, Terry
    Faraone, Stephen V.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2017, 27 (02) : 196 - 199
  • [48] Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use
    Jain, Rakesh
    Babcock, Thomas
    Burtea, Teodor
    Dirks, Bryan
    Adeyi, Ben
    Scheckner, Brian
    Lasser, Robert
    Renna, John
    Duncan, Don
    ADVANCES IN THERAPY, 2013, 30 (05) : 472 - 486
  • [49] Safety outcomes from the clinical development programme for lisdexamfetamine dimesylate: a prodrug stimulant for the treatment of attention-deficit/hyperactivity disorder
    Coghill, David
    Sorooshian, Shaw
    Caballero, Beatriz
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2013, 22 : S224 - S224
  • [50] European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    Coghill, David
    Banaschewski, Tobias
    Lecendreux, Michel
    Soutullo, Cesar
    Johnson, Mats
    Zuddas, Alessandro
    Anderson, Colleen
    Civil, Richard
    Higgins, Nicholas
    Lyne, Andrew
    Squires, Liza
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (10) : 1208 - 1218
12345